John Marshall Bancorp Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 4/6

John Marshall Bancorp hat eine Bilanzsumme von $2.3B und ein Eigenkapital von $243.1M. Die Summe der Einlagen beträgt $1.9B und die Summe der Kredite $1.8B.

Wichtige Informationen

9.4x

Verhältnis von Vermögen zu Eigenkapital

2.2%

Nettozinsspanne

Gesamteinlagen	US$1.94b
Kredit- zu Einlagenverhältnis	Angemessen
Notleidende Kredite	n/a
Wertberichtigung für notleidende Kredite	n/a
Liquiditätskennzahl	Niedrig
Bargeld und Äquivalente	US$177.85m

Jüngste Berichte zur Finanzlage

Keine Aktualisierungen

Recent updates

John Marshall Bancorp's (NASDAQ:JMSB) Dividend Will Be Increased To $0.25

May 22

John Marshall Bancorp's (NASDAQ:JMSB) Upcoming Dividend Will Be Larger Than Last Year's

May 01

If EPS Growth Is Important To You, John Marshall Bancorp (NASDAQ:JMSB) Presents An Opportunity

May 23

John Marshall Bancorp GAAP EPS of $0.57, revenue of $18.14M

Oct 19

John Marshall Bancorp GAAP EPS of $0.56, revenue of $17.42M

Jul 20

We Ran A Stock Scan For Earnings Growth And John Marshall Bancorp (NASDAQ:JMSB) Passed With Ease

Jun 27

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Analyse der Finanzinstitute

Vermögensebene: JMSBDas Verhältnis von Vermögen zu Eigenkapital (9.4x) ist niedrig.

Wertberichtigung für uneinbringliche Kredite: Unzureichende Daten, um festzustellen, ob JMSB über eine ausreichende Wertberichtigung für notleidende Kredite.

Verbindlichkeiten mit geringem Risiko: 95% der Verbindlichkeiten von JMSB bestehen hauptsächlich aus risikoarmen Finanzierungsquellen.

Darlehenshöhe: JMSB ein angemessenes Niveau des Verhältnis von Krediten zu Vermögenswerten aufweist (80%).

Einlagen mit geringem Risiko: JMSBDas Verhältnis von Krediten zu Einlagen (94%) ist angemessen.

Höhe der notleidenden Kredite: Unzureichende Daten, um festzustellen, ob JMSB ein angemessenes Niveau an notleidenden Krediten aufweist.

John Marshall Bancorp Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Recent updates

Independent Director recently sold US$107k worth of stock

Investor sentiment improves as stock rises 22%

Third quarter 2024 earnings released: EPS: US$0.30 (vs US$0.72 loss in 3Q 2023)

New major risk - Revenue and earnings growth

John Marshall Bancorp, Inc. Announces Appointment of Kathryn R. Speakman as Senior Vice President

John Marshall Bancorp's (NASDAQ:JMSB) Dividend Will Be Increased To $0.25

Independent Chairman of the Board recently bought US$52k worth of stock

John Marshall Bancorp's (NASDAQ:JMSB) Upcoming Dividend Will Be Larger Than Last Year's

John Marshall Bancorp, Inc., Annual General Meeting, Jun 18, 2024

Dividend increased to US$0.25

John Marshall Bancorp, Inc. Announces Annual Cash Dividend, Payable on July 8, 2024

Independent Director exercised options to buy US$189k worth of stock.

Investor sentiment deteriorates as stock falls 18%

New minor risk - Share price stability

Investor sentiment improves as stock rises 20%

Investor sentiment improves as stock rises 17%

Independent Director notifies of intention to sell stock

Investor sentiment improves as stock rises 18%

New minor risk - Profit margin trend

Independent Director notifies of intention to sell stock

Second quarter 2023 earnings released: EPS: US$0.32 (vs US$0.56 in 2Q 2022)

Upcoming dividend of US$0.22 per share at 1.0% yield

Now 23% undervalued after recent price drop

Investor sentiment improves as stock rises 21%

If EPS Growth Is Important To You, John Marshall Bancorp (NASDAQ:JMSB) Presents An Opportunity

Investor sentiment deteriorates as stock falls 19%

Now 24% undervalued after recent price drop

Now 20% undervalued after recent price drop

Full year 2022 earnings released: EPS: US$2.27 (vs US$1.87 in FY 2021)

Now 22% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Full year 2022 earnings released: EPS: US$2.27 (vs US$1.87 in FY 2021)

Insufficient new directors

President exercised options to buy US$172k worth of stock.

John Marshall Bancorp, Inc. and John Marshall Bank Announces Resignation of M. Edelman as A Director, Effective December 31, 2022

Third quarter 2022 earnings released: EPS: US$0.57 (vs US$0.50 in 3Q 2021)

John Marshall Bancorp GAAP EPS of $0.57, revenue of $18.14M

Now 21% undervalued after recent price drop

Now 22% undervalued after recent price drop

Independent Director recently sold US$274k worth of stock

Independent Director recently sold US$133k worth of stock

Second quarter 2022 earnings released

John Marshall Bancorp GAAP EPS of $0.56, revenue of $17.42M

We Ran A Stock Scan For Earnings Growth And John Marshall Bancorp (NASDAQ:JMSB) Passed With Ease

Investor sentiment deteriorated over the past week

Now 20% undervalued

John Marshall Bancorp, Inc. announced that it has received $25 million in funding

Independent Director recently sold US$380k worth of stock

John Marshall Bancorp, Inc. Announces Management Changes

First quarter 2022 earnings released: EPS: US$0.55 (vs US$0.37 in 1Q 2021)

Senior EVP recently sold US$315k worth of stock

John Marshall Bancorp, Inc., Annual General Meeting, Jun 22, 2022

Senior EVP recently sold US$58k worth of stock

Insufficient new directors

John Marshall Bank Hires Peter Nadanyi as SVP, Loudoun Commercial Team Lead

John Marshall Bank Promotes Regional Executive, Christopher J. Lipscomb in Arlington Market

Analyse der Finanzlage

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Bilanz

Analyse der Finanzinstitute

Entdecken Sie finanziell stabile Unternehmen